Regeneron

-$2.38 (-0.43%) Today
$0.00 (0.00%) As of 10:33 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Regeneron and other ETFs, options, and stocks.

About REGN

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP.

CEO
Leonard S. Schleifer
Employees
9,123
Headquarters
Tarrytown, New York
Founded
1988

REGN Key Statistics

Market Cap
59.17B
Price-Earnings Ratio
9.98
Dividend Yield
—
Average Volume
809.80K
High Today
$558.20
Low Today
$552.16
Open Price
$557.33
Volume
828.58K
52 Week High
$686.62
52 Week Low
$441.00

REGN News

BenzingaOct 14

Why Regeneron Shares Are Rising Today

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) is trading higher Thursday after the company announced the FDA accepted for priority review a Biologics License App
MarketWatchOct 14

Regeneron is seeking full FDA approval for its monoclonal antibody for two types of COVID-19 patients

Shares of Regeneron Pharmaceuticals Inc. REGN, +0.49% gained 2.7% in premarket trading on Thursday after the company said the Food and Drug Administration accep
BenzingaOct 12

Expert Ratings For Regeneron Pharmaceuticals - Regeneron Pharmaceuticals

Within the last quarter, Regeneron Pharmaceuticals (NASDAQ:REGN) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bear

REGN Earnings

$0.00
$8.60
$17.20
$25.80
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Available Nov 4, Pre-Market

More REGN News

ReutersOct 11

EU assesses Regeneron/Roche COVID-19 antibody cocktail for authorisation

Oct 11 (Reuters) - The European Union's drugs regulator said it was evaluating a marketing authorisation for an antibody cocktail developed by Roche and Regener
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure